Articles Follow-up of children born after assisted reproductive technologies

Similar documents
Overview. In Vitro Fertilization: a Success Story

Article Obstetric and perinatal outcome of 1655 ICSI and 3974 IVF singleton and 1102 ICSI and 2901 IVF twin births: a comparative analysis

Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification

Society for Assisted Reproductive Technology and American Society for Reproductive Medicine

Report to the Director-General of Health on the Risks and Benefits Associated with Assisted Reproductive Technologies

Review of unexplained infertility and obstetric outcome: a 10 year review

Registers of in-vitro fertilization and assisted conception

Reproductive Technologies and the Risk of Birth Defects

Abstract. Introduction. Materials and methods. Patients and methods

Article Influence of spermatogenic profile and meiotic abnormalities on reproductive outcome of infertile patients

Karyotyping, congenital anomalies and follow-up of children after intracytoplasmic sperm injection with non-ejaculated sperm: a systematic review

IVF Health Risk 503,000 Hit in Google in 0.2 seconds

The costs to the NHS of multiple births after IVF treatment in the UK

Article Neonatal and obstetric outcome of pregnancies conceived by ICSI or IVF

CONTROVERSY: MULTIPLE BIRTHS: WHAT DO PATIENTS WANT?

Births following fertility treatment in the GUI infant cohort. Aisling Murray Growing Up in Ireland, ESRI

Imprinting diseases and IVF. Øjvind Lidegaard Dept. Obstetrics & Gynaecology Herlev University Hospital Copenhagen, Denmark

Single embryo transfer: a mini-review

Embryo Selection after IVF

Systematic review of the health risks to the mother, child and family associated with the use of intracytoplasmic sperm injection (ICSI)

IVF/ICSI twin pregnancies: risks and prevention

Supplemental figure 1. Adjusted odds ratios for gestational diabetes, pre-eclampsia, premature birth and miscarriage for women with and without PCOS.

Dr Manuela Toledo - Procedures in ART -

Cognitive development following ART: effect of choice of comparison group, confounding and mediating factors

INTRACYTOPLASMIC SPERM INJECTION

Hum. Reprod. Advance Access published February 3, 2006

Fertility Preservation By Dr Mary Birdsall Chair, Fertility Associates

Supplementary Online Content

International Federation of Fertility Societies. Global Standards of Infertility Care

Committee Paper SCAAC(05/09)01. ICSI guidance. Hannah Darby and Rachel Fowler

Infant and maternal health monitoring using a combined Nordic database on ART and safety

Clinical Policy Committee

Reproductive Technology, Genetic Testing, and Gene Therapy

Louise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization

SINCE THE GOAL OF IN VITRO FERtilization

Increase your chance of IVF Success. PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0)

COGEN Symposium III Barcelona. Presentation by Alastair Sutcliffe Children s Doctor

Cite this article as: BMJ, doi: /bmj ae (published 7 August 2006)

European IVF Monitoring (EIM) Year: 2013

The data were analysed using Fisher s exact test and the chi-squared test.

Risk of Adverse Perinatal Outcomes in Dizygotic Twins After IVF Pregnancies: A Systematic Review

University of Medicine and Dentistry of New Jersey (UMDNJ) New Jersey Medical School, Newark, New Jersey

Autism and Mental Retardation Among Offspring Born After In Vitro Fertilization

Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE

Children born after assisted fertilization have an increased rate of major congenital anomalies

Genetics and Counselling in Reproductive Medicine. Grace Bianchi-Movarekhi

Matthew G. Retzloff, M.D., and Mark D. Hornstein, M.D.

Offspring of subfertile couples: neurodevelopmental outcome at preschool age Schendelaar, Pamela

Perinatal Outcomes by Mode of Assisted Conception and Sub-Fertility in an Australian Data Linkage Cohort

Sperm Donation - Information for Donors

FERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida

Comparison of Growth Parameters of 5-year-old Singleton Children Born in Assisted Versus Natural Conception

ASSISTED PROCREATION: TOO LITTLE CONSIDERATION FOR THE BABIES?

Infertility treatment

Understanding IVF Processes in Surrogacy

CONTROVERSY: INSURANCE COVERAGE

What is the relationship between genes and chromosomes? Is twinning genetic or can a person choose to have twins?

Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome

College of Physicians and Surgeons of Saskatchewan STANDARDS. Assisted Reproductive Technology PREAMBLE

Intracytoplasmic sperm injection: a review of risks and complications

Outlook Results of assisted reproduction techniques in Latin America*

Assisted Reproductive Technology National Summary Report Belgium 2015

Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters

Risk of Spontaneous Abortion in Women with Childhood Exposure to Parental Cigarette Smoke

Clinical Policy Committee

COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA)

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic

Increased Length of Awareness of Assisted Reproductive Technologies Fosters Positive Attitudes and Acceptance among Women

Reproductive Techniques

FACTORS ASSOCIATED WITH DIZYGOTIC TWINNING AFTER IVF TREATMENT WITH DOUBLE EMBRYO TRANSFER

ANZARD 2.0 Data Dictionary V2

Assisted Reproductive Technologies

The first live birth after the transfer

E1. Lifestyle and Fertility

Disclosures. Win Fertility UpToDate

Reproductive Roulette

European IVF Monitoring (EIM) Year: 2012

COMMISSIONING POLICY. Tertiary treatment for assisted conception services

Congenital malformations in infants born after IVF: a population-based study

Commentary Are major defects in children conceived in vitro due to innate problems in patients or to induced genetic damage?

Universal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D.

CONSENT TO FROZEN EMBRYO TRANSFER

Hospital care utilization of IVF/ICSI twins followed until 2 7 years of age: a controlled Danish national cohort study

Keywords: annual reports, international literature, intrauterine insemination, multiple pregnancy, ongoing pregnancy, The Netherlands

Infertility, infertility treatment and twinning: the Danish National Birth Cohort

Does a woman s educational attainment influence in vitro fertilization outcomes?

GENA2. Source Booklet. General Studies (Specification A) General Certificate of Education Advanced Subsidiary Examination June 2011

Abstract. Introduction. RBMOnline - Vol 19. No Reproductive BioMedicine Online; on web 24 August 2009

NHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART)

Life-Span Development Thirteenth Edition

HUMAN FERTILISATION & EMBRYOLOGY AUTHORITY THE SCIENTIFIC AND CLINICAL ADVANCES GROUP

A mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort

FEMALE MEDICAL & REPRODUCTIVE HISTORY (There are 5 pages - please ensure you answer all questions)

Assisted Reproductive Technologies

Preimplantation Genetic Diagnosis (PGD) in Western Australia

The longer-term health outcomes for children born as a result of IVF treatment: Part I General health outcomes

Artigo original/original Article

Infertility. F r e q u e n t l y A s k e d Q u e s t i o n s. Q: What causes infertility in men? A: Infertility in men is most often caused by:

Transcription:

RBMOnline - Vol 5. No 3. 317 322 Reproductive BioMedicine Online; www.rbmonline.com/article/669 on web 9 August 2002 Articles Follow-up of children born after assisted reproductive technologies Dr Michael Ludwig was born in 1968 in Germany and concluded university in 1994. He is Gynaecologist and Obstetrician at the University Hospital Lübeck and is running the Division of Reproductive Medicine and Gynaecologic Endocrinology at the Department of Gynaecology and Obstetrics. Dr Ludwig has published several papers in different fields of reproductive medicine, especially assisted reproductive techniques. His special interests lie in the field of evidence-based reproductive medicine and epidemiological studies in assisted reproductive treatment. Dr M Ludwig Michael Ludwig 1, Klaus Diedrich Department of Gynecology and Obstetrics, University Clinic, Ratzeburger Allee 160, 23538 Lübeck, Germany 1 Correspondence: Tel: +49 451 500 2158; Fax: +49 (0) 451 5059334; e-mail: Ludwig_M@t-online.de Abstract The course of pregnancies and the health of children born after assisted reproductive technologies are two of the most important outcome parameters of the quality of the techniques. There is an ongoing discussion as to whether these parameters may show poorer results as compared with spontaneous conception. Recent studies have shown increased risks for the pregnancy course following conventional IVF (e.g. premature birth, low birthweight), and a higher rate of major malformations after conventional IVF as well as after intracytoplasmic sperm injection. Molecular biological studies may support the idea that these risks are not related to the techniques used, but to parental background factors. Data from surrogate motherhood also demonstrate that here the risk is lower as compared with pregnancies from IVF mothers, who carry their own child to birth. Therefore, there are more infertility related problems than those related to technique. Finally, however, a risk related to the technique itself cannot be excluded completely by currently available data. Keywords: assisted reproductive technologies, congenital malformation, ICSI, IVF Introduction For as long as assisted reproductive technologies have been used, there has been an ongoing discussion as to whether there might be an impact on pregnancy course and especially on the health of children born after those procedures. Until recently, however, the general agreement was that there is no worse outcome of children born following conventional IVF, but that there might be an effect on the health of children born after intracytoplasmic sperm injection (ICSI). The latter seemed to be concentrated on the incidence of chromosomal abnormalities in fetuses and babies born following this procedure (Bonduelle et al., 1998). On the other hand, most studies carried out on children born following conventional IVF were done on a non-controlled, observational basis. Therefore, hard data on the health of these children are based on only a few, recently published studies. Using new data on this topic, this paper tries to give an overview and discussion that may shed light on some points, but also will show which questions have to be addressed in the future. Pregnancy follow-up following conventional IVF The problem of a higher incidence of pregnancy complications became evident in the mid-1980s (Lancaster, 1985). At that time, it had already been considered that certain characteristics of the parents themselves, e.g. the greater age of the mother, would contribute to this risk. However, even after matching for gestational age, parity and maternal age, a higher risk of gestational diabetes and pregnancy-induced hypertension was reported in a recent study (Maman et al., 1998). In a study from Sweden, these risks could not be confirmed for singleton pregnancies following IVF; however, there was a significantly higher rate of premature birth after matching for maternal age, parity, height, weight, ethnic origin, smoking habit, medical disorders, and obstetric history (Koudstaal et al., 2000). Several controlled studies have been done in singleton pregnancies after conventional IVF, all of which have shown consistent results in one point; that there is a higher incidence of pregnancy complications compared with spontaneously conceived children (Doyle et al., 1992; Petersen et al., 1995; 317

D Souza et al., 1997; Bergh et al., 1999). The most consistent finding was a higher prematurity rate and a higher rate of low birth weight. Recently, a study by Schieve et al. from the United States has reported similar findings (Schieve et al., 2002). In this study, 42,463 children born after assisted reproductive technology in the years 1996 and 1997 were compared with 3,389,098 naturally conceived children born in 1997. Assisted reproductive technology in this study was defined by all procedures in which oocytes and spermatozoa were handled outside the body, i.e. conventional IVF, ICSI, GIFT (gamete intra-fallopian transfer), cryopreservation cycles and donor oocyte or embryo cycles. In the study cohort, 43% of children were singletons, 43% were twins, 12% were triplets and 1% were quadruplets or higher order multiples. Looking at all children born, there was a higher rate of low birth weight (<2500 g) in the group of triplets (92.4%) as compared with twins (55.2%), and singletons (13.2%). When only the 16,730 singletons in the study group after adjustment for mother s age were analysed, there was a significantly increased risk for low (relative risk 1.8, 95% confidence interval (CI) 1.7 1.8) and very low birth weight (relative risk 1.7, 95% CI 1.5 1.9). These results are also shown in Table 1. These data confirm that the main risk of prematurity is due to the multiple pregnancy rate, but there remains a risk of low birth weight and very low birth weight, even when only singletons are analysed. The presence or absence of a male factor seems not to have an impact in this study. In parallel, another study showed the problem of multiple pregnancies with regard to children s health (Strömberg et al., 2002). This group from Sweden demonstrated in a register based study that the risk for neurological sequelae in children born after IVF was 1.4 times higher as compared with spontaneously conceived children. In their study, the authors included a group of 5680 children born after IVF, and 11,360 matched controls. For the 2060 twins in the IVF group, a second control group of 4120 spontaneously conceived twins was chosen. The neurological performance was studied using data from the Swedish habilitation centres. Stratification for the controls was performed for sex, year of birth and birth hospital. The risk to get in contact with a childhood disability centre was 1.7 (95% CI 1.3 2.2) for all IVF children as compared with controls (2% versus 1%). For singletons the risk was 1.4 (95% CI 1.0 2.1) (1.4% versus 1.0%). After performing a logistic regression analysis, only gestational age and birthweight had a significant influence on the risk of getting in contact with a childhood disability centre, but a history of IVF, maternal age <30 or >35 years, or male sex did not. The most substantial risk for cerebral palsy in this analysis in singletons also was low birth weight (12.4, 95% CI 5.2 29.3) and low gestational age (5.5, 95% CI 2.3 13.3); IVF was not a significant risk factor. Therefore, the conclusion was that it is largely the high number of multiple births that leads to the increase in risk of neurological problems in these children, and not the IVF procedure itself (Strömberg et al., 2002). On the other hand, again the previously described risk of having low birth weight and being born premature might influence this risk especially in the IVF cohort. Finally, another group from Sweden showed that it is also mainly the rate of multiple pregnancies which contributes to a higher number of hospital stays in children born after IVF (Ericson et al., 2002). Very interestingly, the above-cited study by Schieve et al. also included a group of surrogate mothers, not suffering from infertility, but treated by IVF to carry the child of another couple (Schieve et al., 2002). In this group, there was no increased risk, either for low or very low birthweight (Table 1). This confirms that it is not a procedure, but an infertility related risk, which contributes to the higher prematurity rate. Table 1. Results of a retrospective, register-based analysis of singleton births following assisted reproductive technology in the United States (adapted from Schieve et al., 2002). Outcome parameter Total number Number of cases Standardized risk observed ratio (95% CI) Low birth weight (<2500 g) All infants 18,398 2423 1.8 (1.7 1.9) Pregnancies with one fetal heart 16,730 2104 1.8 (1.7 1.8) Use of donor oocytes, 1397 190 1.6 (1.4 1.8) no male factor infertility Diagnosis of male factor infertility 2795 329 1.7 (1.5 1.9) Use of gestational carrier 180 16 1.2 (0.6 1.8) Very low birth weight (<1500 g) 318 All infants 18,398 480 1.8 (1.7 2.0) Pregnancies with one fetal heart 16,730 408 1.7 (1.5 1.9) Use of donor oocytes, 1397 49 2.1 (1.5 2.7) no male factor infertility Diagnosis of male factor infertility 2795 78 2.0 (1.6 2.5) Use of gestational carrier 180 0

Others have shown a similar infertility related risk before. Pandian et al. (2001) have demonstrated that women suffering from idiopathic infertility show an increased risk of preeclampsia, placental abruption, premature delivery and emergency Caesarean section. All these risks were independent from treatment-induced pregnancies or spontaneous pregnancies. Therefore, the authors concluded for this special group of patients, that infertility treatment per se does not increase either the complication rate or the rate of intervention in these women. To conclude for this point, pregnancies following an IVF procedure seem to be at a higher risk for pregnancy complication and premature birth. This risk is largely due to the higher rate of multiple pregnancies, but there remains a risk related only to the infertility of the mothers. Regarding neurological problems, no higher risk is associated with the IVF procedure itself. Malformation risk in children born after conventional IVF and ICSI It has been an accepted fact in the past, that children born following conventional IVF do not have an increased risk of congenital malformations. Looking through the literature, there are, however, only a small number of controlled studies, which have addressed this topic. Recently, a study published in the New England Journal of Medicine has shown an increased risk of congenital malformations in IVF as well as in ICSI children (Table 2) (Hansen et al., 2002). Table 2. Risk of major malformations in children born after conventional IVF or ICSI in Western Australia as compared with spontaneously conceived children. Results of a retrospective, register based analysis. Shown are the data regarding pregnancy outcome (singletons only) in the three studied cohorts (a) as well as the relative risk for a major malformation (b) (adapted from Hansen et al., 2002). (a) Outcome parameter ICSI P-value a IVF P-value a Natural conception Stillborn n (%) 0 6 (1) 25 (1) Birth weight (g) 3271 ± 552 0.02 3182 ± 686 <0.001 3368 ± 571 Preterm delivery (<37 week of 16 (9) 73 (14) 0.001 225 (6) gestation) n (%) Low birth weight (<2500 g) n (%) 12 (6) 38 (7) 0.002 163 (4) Very low birth weight (<1500g) n (%) 2 (1) 19 (4) <0.001 41 (1) Gestational age (weeks) 38.6 ± 2.2 38.0 ± 3.0 0.03 39.1 ± 2.0 Values are mean ± SD, if not otherwise defined. a In relation to natural conception. (b) Group Children (n) Prevalence of Adjusted odds major malformation ratio (95% CI) All infants Natural conception 4000 168 (4.2) 1.0 ICSI 301 26 (8.6) 2.0 (1.3 3.2) IVF 837 75 (9.0) 2.0 (1.5 2.9) All singletons Natural conception 3906 164 (4.2) 1.0 ICSI 186 18 (9.7) 2.2 (1.3 3.9) IVF 527 50 (9.5) 2.2 (1.5 3.2) Term singletons Natural conception 3681 149 (4.0) 1.0 ICSI 170 15 (8.8) 2.2 (1.2 4.0) IVF 454 38 (8.4) 2.1 (1.4 3.2) 319

320 In this study 301 infants conceived with ICSI, 837 infants conceived with conventional IVF, and 4000 spontaneously conceived children were compared. Risk factors in the parents included a higher maternal age, and a lower incidence of having had a child previously. Regarding pregnancy outcome, i.e. gestational age, premature birth rate, low and very low birth weight, there were again significant differences for IVF as compared with naturally conceived children (Table 2). The risk of having a major malformation was significantly increased by 2-fold, independent of whether conventional IVF or ICSI was performed. To exclude a reporting bias, i.e. to over-report malformations in the cohorts of children conceived by assisted reproductive technology directly after birth, the authors looked for registered malformations up to 1 year of age. These data are based on a large cohort of spontaneously conceived children and several hundred children conceived after assisted reproductive technology. Of course, there are studies based on a higher number of infants (e.g. Bonduelle et al., 2002), but it is unlikely that the study results would change if a higher number of children were included. It may be a major drawback that this study was done retrospectively. It is impossible to exclude a reporting bias for the different cohorts, especially since reports from Australia in the past have proposed a higher risk for children conceived by ICSI (Kurinczuk and Bower, 1997), and therefore paediatricians may have been more likely to report any malformation to the registers. Another drawback is that an adjustment could be made for only for a limited number of background risk factors of the parents, since only a limited number of those factors were collected in the register based data set. However, we may assume, that even by this the relative risk might decrease but will not disappear totally. It has recently been shown in a prospective controlled study in a cohort of 3372 fetuses and infants conceived by ICSI, that the risk for a major malformation was increased by 1.25-fold (95% CI 1.10 1.46) (see Table 3, repeated from Ludwig and Katalinic, 2002). The risk for children born after ICSI was exactly the same as that described by Henson et al. (2002). The Table 3. Risk of having a major malformation. Data from a prospective, controlled study including fetuses and infants from pregnancies after ICSI as compared with spontaneous conception. All pregnancies were analysed, which ended after week 16 of gestation by spontaneous abortion, induced abortion, stillbirth or livebirth (see Ludwig and Katalinic, 2002) a. ICSI cohort (n) RR (95% CI) Malformation rate 8.6 (291/3372) 1.25 (1.10 1.46) (total) (%) Origin of spermatozoa b Ejaculated 8.4 (248/2944) 1.0 Testicular 9.2 (21/229) 0.92 (0.60 1.41) Epididymal 3.8 (1/26) 2.19 (0.32 15.02) a Table previously published (Ludwig et al., 2002) and reprinted with permission. b Information not available for 173 children/fetuses. risk did not depend on the origin of spermatozoa in the ejaculate. Bonduelle et al. may have carried out the largest prospective, controlled cohort study, which compared pregnancies conceived after IVF to those conceived after ICSI (Bonduelle et al., 2002). In the most recent analysis, they reported on a cohort of 2889 infants born after ICSI and 2995 infants born after IVF. The results of this study are summarized in Table 4. There were no significant differences regarding pregnancy outcome parameters, and especially no differences regarding the major malformation rates. The data from this study do not contradict the results of the Western Australian study (Hansen et al., 2002), since the malformation rate was similar between IVF and ICSI children, but no control group of spontaneously conceived children was included. Two other recently published studies have also contributed this discussion (Wennerholm et al., 2000; Ericson and Kallen, 2001). Both studies have described a significant increase in the malformation rate following ICSI. This was, however, not found after adjustment of background risk factors (Table 5). The only malformation, that was still found to be increased following ICSI in both analyses was the risk for hypospadias. This was thought by the authors to be related to genetic factors causing male factor infertility. Finally, there remains the possibility of a higher incidence of gonosomal abnormalities in children born after ICSI (Bonduelle et al., 1998). Here, the risk was said to be increased from ~0.2% to ~0.8%. In a more recent analysis of the same group in a larger cohort of children, the risk in children born after ICSI had decreased to 0.63% but was still increased as compared with naturally conceived children (Bonduelle et al., 2002). There is an ongoing debate as to whether these differences are related to ICSI itself or are related to genetic abnormalities in the spermatozoa of men suffering from male subfertility. In two recent reviews, different possibilities, molecular-biological findings and theories have been discussed (Ludwig et al., 2001; Schröder et al., 2001). It was concluded that it is unlikely that ICSI contributes to this abnormality, but rather that parental background risk factors are responsible. Furthermore, a recent publication has confirmed that paternal genetic abnormalities in spermatozoa are a more likely cause of genetic abnormalities in the offspring than the ICSI technique itself (Sbracia et al., 2002). Conclusion There is increasing evidence that pregnancies following conventional IVF show more complications than those after spontaneous conception. It is still uncertain if this is also true of pregnancies resulting from ICSI. Data from surrogate pregnancies, however, show, that the risks following conventional IVF seem not to be linked to the assisted reproductive technology procedure, but to risk factors of the infertile mothers, since, e.g. the risk of premature birth and low birthweight is not increased in the pregnancies of surrogate mothers.

Table 4. Results of a prospective, controlled study comparing infants born after ICSI to those born after conventional IVF. Pregnancy follow-up and examination of children was performed according to a standardized procedure (adapted from Bonduelle et al., 2002). Outcome parameter ICSI IVF P-value Infants (n) 2889 2995 Stillbirths n (%) 49 (1.7) 40 (1.3) NS Gestational age (weeks) 37.9 ± 2.6 37.9 ± 2.8 NS Birthweight (g) Total group 2806 ± 719 2765 ± 725 NS Singletons 3224 ± 581 3176 ± 582 NS Twins 2394 ± 522 2382 ± 560 NS Triplets 1761 ± 548 1768 ± 497 NS Birthweight <2500 g (only singletons) n (%) 106 (7.1) 121 (7.8) NS Birthweight <1500 g (only singletons) n (%) 22 (1.5) 28 (1.8) NS Prematurity (<37 weeks of gestation) (only singletons) n (%) 126 (8.4) 140 (9.0) NS Admission to neonatal unit (only singletons) n (%) 261 (17.5) 289 (18.7) NS Major malformation n (%) 122/2889 (4.22) 135/2895 (4.66) NS NS = no significant difference. Table 5. Malformation risk following ICSI in two Swedish studies. After adjustment for background risk factors, there was only a risk left for the prevalence of hypospadias. Shown are relative risks (95% confidence intervals). Adapted from Wennerholm et al. (2000) and Ericson and Källen (2001). Analysis of data from the Swedish Medical Birth Registry and Registry of Congenital Malformation (n = 1139) (Wennerholm et al., 2000) Risk for major malformation 1.75 (1.19 2.58) a after ICSI After stratification for multiples 1.19 (0.79 1.81) Hypospadias 3.0 (1.09 6.50) Analysis of data from the Swedish Medical Birth Registry and Registry of Congenital Malformation for all IVF births (n = 9175) (Ericson and Källén, 2001) Risk for major malformation after ICSI 1.47 (1.34 1.61) b After stratification 0.89 (0.74 1.06) c Hypospadias (only ICSI) 1.36 (1.19 1.56) a Adjusted for: year of birth, delivery hospital, maternal age. b Adjusted for: year of birth. c Adjusted also for: maternal age and parity, number in birth, multiples, time of involuntary childlessness. Regarding malformation rates, the risk of genetic abnormalities is increased after ICSI. This is in part due to known chromosome abnormalities, especially in the fathers. On the other hand, even without chromosome abnormalities in the parents, more gonosomal abnormalities are found in the offspring. Here, genetic factors, such as a higher rate of gonosomal aberrations in spermatozoa, might be responsible. Also, the risk of major malformation in general seems to be higher in pregnancies after ICSI as compared with those after spontaneous conception. It seems unlikely that this is due to the procedure itself, although this cannot definitely be excluded. Again, parental factors, especially of genetic origin, seem to be a major factor. Future studies will prove whether this risk can be attributed to a more narrowly defined group of patients, and whether this risk is also apparent for pregnancies following conventional IVF. An ideal study to address the question of congenital malformation could be done by prospectively randomizing patients who have an indication to be treated by IVF to either conventional IVF or ICSI. Children would have to be evaluated by a standardized procedure, including sonography of hips and kidneys and echocardiography in case of clinical abnormalities. This should be done by a small group of neonatologists, who are unaware of the assisted reproductive technology procedure used. Since it is unethical to randomize fertile patients for the assisted reproductive technology procedures, it is difficult to include a real control group. Perhaps a second group should be randomized, consisting of surrogate mothers. Finally, a group of spontaneously 321

322 conceived children should be evaluated according to the same procedure as the children born after assisted reproductive technology. Until that time, parents should be counselled that a techniquerelated risk cannot be excluded totally. Since this paper was originally drafted, two ICSI children have been born with Angelman s syndrome (Cox et al., 2002). This raises the possibility of ICSI disturbing epigenetic processes occurring at fertilization (Arney et al., 2002). Although this case report alone is insufficient to claim this as fact, it provides further support for the view that the health of children born by assisted reproductive technology procedures should be closely monitored, particularly for those syndromes and malformations that are known to be the result of imprinting errors. References Arney RL, Bao S, Bannister AJ et al. 2002 Histone methylation defines epigenetic asymmetry in the mouse zygote. International Journal of Developmental Biology 46, 317 320. Bergh T, Ericson A, Hillensjo T et al. 1999 Deliveries and children born after in-vitro fertilisation in Sweden 1982 95: a retrospective cohort study. Lancet 354, 1579 1585. Bonduelle M, Aytoz A, Wilikens A et al. 1998 Prospective follow-up study of 1987 children born after intracytoplasmic sperm injection (ICSI). In: M Filicori and C Flamigni (eds) Treatment of Infertility: the New Frontiers. Communications Media for Education, New Jersey, pp. 445 461. Bonduelle M, Liebaers I, Deketelaere V et al. 2002 Neonatal data on a cohort of 2889 infants born after ICSI (1991 1999) and of 2995 infants born after IVF (1983 1999). Human Reproduction 17, 671 694. Cox GF, Burger J, Lip V et al. 2002 Intracytoplasmic sperm injection may increase the risk of imprinting defects. American Journal of Human Genetics 71, 162 164. Doyle P, Beral V, Maconochie N 1992 Preterm delivery, low birthweight and small-for-gestational-age in liveborn singleton babies resulting from in-vitro fertilization. Human Reproduction 7, 425 428. D Souza SW, Rivlin E, Cadman J et al. 1997 Children conceived by in vitro fertilisation after fresh embryo transfer. Archives of Disease in Childhood Fetal and Neonatal Edition 76, F70 F74. Ericson A, Kallen B 2001 Congenital malformations in infants born after IVF: a population-based study. Human Reproduction 16, 504 509. Ericson A, Nygren KG, Olausson PO, Kallen B 2002 Hospital care utilization of infants born after IVF. Human Reproduction 17, 929 932. Hansen M, Kurinczuk JJ, Bower C, Webb S 2002 The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. New England Journal of Medicine 346, 725 730. Koudstaal J, Braat DD, Bruinse HW et al. 2000 Obstetric outcome of singleton pregnancies after IVF: a matched control study in four Dutch university hospitals. Human Reproduction 15, 1819 1825. Kurinczuk JJ, Bower C 1997 Birth defects in infants conceived by intracytoplasmic sperm injection: an alternative interpretation. British Medical Journal 315, 1260 1266. Lancaster PA 1985. Obstetric outcome. Clinical Obstetrics and Gynaecology 12, 847 864. Ludwig M, Katalinic A 2002 Malformation rate in fetuses and children conceived after intracytoplasmic sperm injection: results of a prospective cohort study. Reproductive BioMedicine Online 5, 171 178. Ludwig M, Schröder AK, Diedrich K 2001 Impact of intracytoplasmic sperm injection on the activation and fertilization process of oocytes. Reproductive BioMedicine Online 3, 228 238. Maman E, Lunenfeld E, Levy A et al. 1998 Obstetric outcome of singleton pregnancies conceived by in vitro fertilization and ovulation induction compared with those conceived spontaneously. Fertility and Sterility 70, 240 245. Pandian Z, Bhattacharya S, Templeton A 2001 Review of unexplained infertility and obstetric outcome: a 10 year review. Human Reproduction 16, 2503 2510. Petersen K, Hornnes PJ, Ellingsen S et al. 1995 Perinatal outcome after in vitro fertilisation. Acta Obstetrica et Gynecologica Scandinavica 74, 129 131. Sbracia M, Baldi M, Cao D et al. 2002 Preferential location of sex chromosomes, their aneuploidy in human sperm, and their role in determining sex chromosome aneuploidy in embryos after ICSI. Human Reproduction 17, 320 324. Schieve LA, Meikle SF, Ferre C et al. 2002 Low and very low birth weight in infants conceived with use of assisted reproductive technology. New England Journal of Medicine 346, 731 737. Schröder AK, Diedrich K, Ludwig M 2001 Fertilization and preimplantation development after intracytoplasmic sperm injection. Reproductive BioMedicine Online 3, 241 249. Strömberg B, Dahlquist G, Ericson A et al. 2002 Neurological sequelae in children born after in-vitro fertilisation: a population based study. Lancet 359, 461 465. Wennerholm UB, Bergh C, Hamberger L et al. 2000 Incidence of congenital malformations in children born after ICSI. Human Reproduction 15, 944 948. Paper based on contribution presented at the Second Expert Organon meeting in Rottach-Egern, Germany, March 2002.